Drug availability adjustments in population-based studies of prescription opioid abuse-Reference-Cited by-同舟云学术

Drug availability adjustments in population-based studies of prescription opioid abuse

Published:2016-12-21 Issue:2 Volume:26 Page:180-191
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Secora Alex¹,Trinidad James Phillip¹,Zhang Rongmei²,Gill Rajdeep¹,Dal Pan Gerald¹

Affiliation:

1. Office of Surveillance and Epidemiology, Division of Epidemiology, Center for Drug Evaluation and Research (CDER); Food and Drug Administration (FDA); USA

2. Office of Biostatistics; Division of Biometrics VII, CDER, FDA; USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference20 articles.

1. Characteristics of opioid prescriptions in 2009;Volkow;JAMA,2011

2. Prescription drug abuse: problem, policies, and implications;Phillips;Nurs Outlook,2013

3. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009;Calcaterra;Drug Alcohol Depend,2013

4. Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits;Davis;Pharmacoepidemiol Drug Saf,2014

5. Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004-2008;Cai;J Pain Palliat Care Pharmacother,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug product dispensing and estimates of use in a general population survey as a signal detection problem;Pharmacoepidemiology and Drug Safety;2021-05-10

2. Real-World Data on Nonmedical Use of Tramadol from Patients Evaluated for Substance Abuse Treatment in the NAVIPPRO Addiction Severity Index—Multimedia Version (ASI-MV®) Network;Drug Safety;2020-11-11

3. Strengths and weaknesses of existing data sources to support research to address the opioids crisis;Preventive Medicine Reports;2020-03

4. Interpol review of controlled substances 2016–2019;Forensic Science International: Synergy;2020

5. Pharmacoepidemiologic Research on Drugs of Abuse;Pharmacoepidemiology;2019-10-18